Bevacizumab tested for treatment of knee osteoarthritis via inhibition of synovial vascular hyperplasia in rabbits

BACKGROUND/OBJECTIVE: Osteoarthritis (OA) is the most common joint disorder. Angiogenesis and synovial hyperplasia are important factors in the development of OA. Previous studies demonstrated that bevacizumab, an antibody against vascular endothelial growth factor in angiogenesis for cancer treatme...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Wei, Lin, Jianjing, Wang, Zhanwei, Ren, Shiyou, Wu, Xiao, Yu, Fei, Weng, Jian, Zeng, Hui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Chinese Speaking Orthopaedic Society 2019
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6896677/
https://www.ncbi.nlm.nih.gov/pubmed/31844612
http://dx.doi.org/10.1016/j.jot.2019.04.002

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6896677/
https://www.ncbi.nlm.nih.gov/pubmed/31844612
http://dx.doi.org/10.1016/j.jot.2019.04.002

Ejemplares similares